Pliant Therapeutics (PLRX) Insider Trading & Ownership → How to camouflage a factory of 53,000 workers (From Stansberry Research) (Ad) Free PLRX Stock Alerts $12.52 -0.08 (-0.63%) (As of 04/23/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Pliant Therapeutics (NASDAQ:PLRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.60%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$3.47 M Get PLRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Pliant Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PLRX Insider Buying and Selling by Quarter Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 Pliant Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/17/2024Bernard CoulieCEOSell25,721$17.23$443,172.83 1/17/2024Hans HullInsiderSell9,786$17.23$168,612.78 1/17/2024Keith Lamont CummingsCFOSell9,781$17.23$168,526.63 1/17/2024Mike OuimetteGeneral CounselSell5,197$17.23$89,544.31 8/3/2023Hans HullInsiderSell13,069$20.00$261,380.00 7/20/2023Mike OuimetteGeneral CounselSell4,755$17.55$83,450.25 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 7/17/2023Bernard CoulieCEOSell70,150$18.01$1,263,401.50 7/17/2023Eric LefebvreInsiderSell22,321$18.01$402,001.21 7/17/2023Keith Lamont CummingsCFOSell19,771$18.01$356,075.71 7/17/2023Mike OuimetteGeneral CounselSell12,778$18.01$230,131.78 (Data available from 1/1/2013 forward) PLRX Insider Trading Activity - Frequently Asked Questions Who is on Pliant Therapeutics's Insider Roster? The list of insiders at Pliant Therapeutics includes Bernard Coulie, Eric Lefebvre, Hans Hull, Keith Lamont Cummings, and Mike Ouimette. Learn more on insiders at PLRX. What percentage of Pliant Therapeutics stock is owned by insiders? 5.60% of Pliant Therapeutics stock is owned by insiders. Learn more on PLRX's insider holdings. Which Pliant Therapeutics insiders have been selling company stock? The following insiders have sold PLRX shares in the last 24 months: Bernard Coulie ($6,608,558.89), Eric Lefebvre ($3,420,810.31), Hans Hull ($429,992.78), Keith Lamont Cummings ($2,022,922.84), and Mike Ouimette ($1,440,137.19). How much insider selling is happening at Pliant Therapeutics? Insiders have sold a total of 568,015 Pliant Therapeutics shares in the last 24 months for a total of $13,922,422.01 sold. More Insider Trading Tools from MarketBeat Related Companies: ARCT Insider Trades TNGX Insider Trades TYRA Insider Trades ELVN Insider Trades OPK Insider Trades ALXO Insider Trades AUPH Insider Trades IRON Insider Trades ETNB Insider Trades NRIX Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NASDAQ:PLRX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pliant Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.